Critical Care , Critical Care Alert , COVID-19

Critical Care Alert: Convalescent Plasma in Patients Admitted with COVID-19 (RECOVERY)

8/2/2021 Nicholas Huth , Brian Sumner, MD

As the coronavirus continues to mutate, researchers are examining every treatment option. This study looks at the efficacy of convalescent plasma for patients admitted to the hospital with COVID-19.

Critical Care , Critical Care Alert

Critical Care Alert: Outcome Related to Level of TTM in Postcardiac Arrest Syndrome of Low, Moderate, and High Severities: A Nationwide Multicenter Prospective Registry

5/2/2021 Nicholas Huth , Brian Sumner, MD , Jonathan Pickos, DO

A nationwide registry has shown targeted temperature management at a lower core temperature led to significantly better neurologic outcomes and survival at 30 days in patients with moderately severe p

Critical Care , Critical Care Alert

Critical Care Alert: Venoarterial Extracorporeal Membrane Oxygenation in Massive Pulmonary Embolism-Related Cardiac Arrest: A Systematic Overview

4/9/2021 Nicholas Huth , Brian Sumner, MD , Jonathan Pickos, DO

This Critical Care Alert examines a study of VA-ECMO on survival and predictors of mortality in patients who suffered massive pulmonary embolism-related cardiac arrest.

Critical Care , Critical Care Alert , COVID-19

Critical Care Alert: Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure (The HOT-ICU Trial)

3/22/2021 Nicholas Huth , Jonathan Pickos, DO , Brian Sumner, MD

The ideal oxygenation goal in patients with acute respiratory failure in the ICU remains unclear. The HOT ICU trial seeks to provide insight.

Critical Care , Critical Care Alert , Cardiology , Sepsis

Critical Care Alerts: Effect of Ultra-Short-Acting Beta-blockers on Mortality in Patients with Persistent Tachycardia Despite Initial Fluid Resuscitation: A Systematic Review and Meta-Analysis

3/3/2021 Nicholas Huth , Jonathan Pickos, DO , Brian Sumner, MD

The latest EMRA Critical Care Alert examines a study that questions whether ultra-short-acting beta-blockers, such as esmolol and landiolol, reduced 28-day mortality in septic patients with persistent